Kazakhstan plans to start the online sales of prescription drugs in 2020

The Ministry of Health of the Republic of Kazakhstan is planning to switch to compulsory e-distribution of all prescription drugs from 2020.

This will require the integration of MISs (medical information systems) with existing ISDS (information systems for drug supply), patient registries and the Unified Information Pharmaceutical System of SK-Pharmacy, that will enable registration of ambulatory patients and their 100% coverage with prescriptions.

The sale of drugs in pharmacies in Kazakhstan against a prescription is not an innovation of the Ministry of Health of the Republic of Kazakhstan. The ban on the sale of prescription drugs without a prescription is valid for more than 16 years and intends to tighten control over the use of drugs, which can lead to a threat to the health and life of the population.

As of October 1, 2018, more than 8,000 drugs were registered in Kazakhstan, with more than 6 thousand out of them being prescription drugs (77%), while without a prescription – more than 1,800 drugs.

Prescription drugs include antimicrobials and hormones; drugs containing narcotic and psychotropic substances; medications for the treatment of cardiovascular diseases, diseases of the gastrointestinal tract, antibiotics, etc.

"GMP news" is a Portal about international GMP Standard for pharmaceutical professionals and specialists, managers, and students. We provide coverage of the most important news in pharmaceutical trade accompanied by topical articles and press realeases from the forerunners of pharmaceutical industry. More about GMP news